New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Eikon Therapeutics, Inc. (EIKN) vs Q32 Bio Inc. (QTTB)

Eikon Therapeutics, Inc. and Q32 Bio Inc. are both Biotechnology companies. Eikon Therapeutics, Inc. and Q32 Bio Inc. are of similar size ($257.9M and $253.8M). Eikon Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Across the 9 metrics below, Q32 Bio Inc. leads on 7 and Eikon Therapeutics, Inc. on 2.

Valuation

Metric EIKN QTTB Biotechnology median
P/E n/m 2.49 8.49
P/S — n/m 8.56
P/B 0.67 0.99 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA 0.61 0.15 0.69
EV/Sales — 0.78 8.00
Earnings yield (670.53%) 40.19% (35.81%)
Free cash flow yield (103.42%) (7.04%) (25.41%)

Profitability

Metric EIKN QTTB Biotechnology median
Gross margin — 100.00% 70.18%
Operating margin — 725.53% 0.00%
Net margin — 808.04% 0.00%
Free cash flow margin — 280.89% 0.00%
Return on equity 359.35% 23.96% (51.58%)
Return on assets (56.31%) 18.17% (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EIKN QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 7.20%
EPS growth (last fiscal year) (19.15%) 136.78% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric EIKN QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.21 56.34 4.79
Net debt to EBITDA 1.07 (2.21) 1.01

Dividend

Metric EIKN QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EIKN QTTB Biotechnology median
Market cap 257.93m 253.75m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack